OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year
08. November 2022 16:05 ET
|
OraSure Technologies, Inc.
InteliSwab® revenue of $79.6 million in Q3, up 85% sequentially;Company continues to expand test production capacity Company wins new contracts for COVID-19 testing along with retail wins including...
OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)
03. November 2022 09:15 ET
|
OraSure Technologies, Inc.
FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha1- Antripsyn Deficiency (Alpha-1) in U.S. Adult Population BETHLEHEM, Pa., Nov. 03, 2022 (GLOBE...
InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store
02. November 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET
01. November 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 third quarter financial results and...
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test
28. September 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention
20. September 2022 16:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Sept. 20, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health
14. September 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year
09. August 2022 16:05 ET
|
OraSure Technologies, Inc.
InteliSwab® revenue of $43.1 million in Q2, up 95% sequentially with significant scaling in production InteliSwab® gross margins improve sequentially by over 2,000 basis points GAAP gross...
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET
02. August 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 second quarter financial results and...
OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack
28. Juli 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., July 28, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...